On the same day the CDC announced its new diabetes guidelines, President Trump signed an executive order calling for states to use “any available state resources” to give patients with Type 1 diabetes the medications they need to treat the condition.
The orders come as many U.S. states have already expanded Medicaid and expanded their health insurance programs to cover people with pre-existing conditions.
But the new guidance doesn’t say how to make the medications available.
It also doesn’t address the long-term effects of a lack of medication, a question the U.N. agency is considering.
“We’re not going to take this position on a hypothetical,” said the CDC’s Dr. Jennifer Kuznia.
“We’re going to have to have data that we have on what the long term impact is of this.”
The new guidelines will apply to people with Type 2 diabetes and to adults with pre/existing conditions with the condition who have Type 1.
People with Type1 diabetes are considered too sick to work or have other job-related health problems.
They also have limited exercise and a poor diet.
The U.K. and France have already given some of the medications to people.
Many of those countries have been using them since the 1980s, and they have seen the numbers jump.
More than half of U.L.A. residents are Type 1 and the number has risen from 2.7% in 1980 to 3.6% today, according to data from the U of L Medical Center.
In the U, about 40% of adults have Type1.
The rest are Type 2.
In 2015, about 8.3 million people in the U had Type1 and the percentage had increased to 17.2% in 2019, according the Centers for Disease Control and Prevention.
The new guidance does not address the risks of not having access to the medications, including the potential for side effects.
The CDC said the new guidelines are not about forcing people to have diabetes, which is “not a good thing.”
But it said it’s important for people to understand the risks associated with not having the medications.
“I think that if you have Type2 diabetes, you’re going not only at increased risk of developing diabetes, but you’re also at increased risks of complications from complications from your underlying disease,” Kuzyna said.
The guidelines do not cover individuals with Type 3 diabetes.
The Centers for Medicare and Medicaid Services said people with type 3 diabetes should seek health care and be tested.